Oncology & Cancer
Treatment for recurrent uterine cancer advances to next research phase
The latest trial of a new antibody drug that delivers potent chemotherapy directly to cancer cells for patients with advanced or recurrent endometrial cancer moves ahead to be studied further in a Phase III trial.
Aug 1, 2024
0
0